http://bmctoday.net/citoday/ The latest news stories from Cardiac Interventions Today. en-us Sun, 14 Mar 2010 02:55:44 GMT Sun, 14 Mar 2010 02:55:44 GMT BMCToday http://bmctoday.net/citoday/2010/02/article.asp?f=edwards--sapien-xt-valve-and-delivery-systems-receive-ce-mark March 2, 2010—Edwards Lifesciences (Irvine, CA) announced that it has received CE Mark approval for the Edwards Sapien XT transcatheter aortic heart valve, as well as its NovaFlex transfemoral and Ascendra 2 transapical delivery systems. The company is beginning a limited European launch of the new valve and the 18-F NovaFlex delivery sy... Tue, 2 Feb 2010 04:00:00 GMT http://bmctoday.net/citoday/2010/02/article.asp?f=edwards--sapien-xt-valve-and-delivery-systems-receive-ce-mark http://bmctoday.net/citoday/2010/02/article.asp?f=st-jude-medicals-engage-introducer-devices-approved-in-united-states-and-europe March 11, 2010—St. Jude Medical, Inc. (St. Paul, MN) announced US Food and Drug Administration clearance and European CE Mark approval for the Engage and Engage TR introducers for use in diagnostic and interventional cardiac catheterization procedures. The Engage family of introducers incorporates features that offer more control and minimize ris... Tue, 2 Feb 2010 04:00:00 GMT http://bmctoday.net/citoday/2010/02/article.asp?f=st-jude-medicals-engage-introducer-devices-approved-in-united-states-and-europe http://bmctoday.net/citoday/2010/02/article.asp?f=syntax-compares-cabg-and-stenting-in-diabetic-patients March 9, 2010—In the Journal of the American College of Cardiology, Adrian P. Banning, MD, et al published findings from a study designed to compare contemporary surgical revascularization (coronary artery bypass graft surgery [CABG]) versus stenting with the Taxus Express paclitaxel-eluting stents (PES) (Boston Scientific Corporation, ... Tue, 2 Feb 2010 04:00:00 GMT http://bmctoday.net/citoday/2010/02/article.asp?f=syntax-compares-cabg-and-stenting-in-diabetic-patients http://bmctoday.net/citoday/2010/02/article.asp?f=study-conducted-of-long-term-pulmonary-regurgitation-after-balloon-valvuloplasty March 9, 2010—According to David M. Harrild, MD, et al, balloon pulmonary valvuloplasty relieves pulmonary stenosis (PS) but can cause late pulmonary regurgitation (PR); however, the sequelae of isolated PR are not well understood. Therefore, the investigators conducted a study that sought to examine the prevalence and predictors of PR af... Tue, 2 Feb 2010 04:00:00 GMT http://bmctoday.net/citoday/2010/02/article.asp?f=study-conducted-of-long-term-pulmonary-regurgitation-after-balloon-valvuloplasty http://bmctoday.net/citoday/2010/02/article.asp?f=stentys-self-expanding-stent-approved-in--europe-to-treat-acute--coronary-syndromes March 5, 2010—Stentys, Inc. (Princeton, NJ) announced that it has received CE Mark approval for its self-expanding and disconnectable stent to treat acute coronary syndromes. According to the company, the self-expanding feature is designed to ensure optimal apposition of a stent in the critical initial hours and day... Tue, 2 Feb 2010 04:00:00 GMT http://bmctoday.net/citoday/2010/02/article.asp?f=stentys-self-expanding-stent-approved-in--europe-to-treat-acute--coronary-syndromes http://bmctoday.net/citoday/2010/02/article.asp?f=stentys-self-expanding-stent-approved-in--europe-to-treat-acute--coronary-syndromes March 5, 2010—Stentys, Inc. (Princeton, NJ) announced that it has received CE Mark approval for its self-expanding and disconnectable stent to treat acute coronary syndromes. According to the company, the self-expanding feature is designed to ensure optimal apposition of a stent in the critical initial hours and day... Tue, 2 Feb 2010 04:00:00 GMT http://bmctoday.net/citoday/2010/02/article.asp?f=stentys-self-expanding-stent-approved-in--europe-to-treat-acute--coronary-syndromes http://bmctoday.net/citoday/2010/02/article.asp?f=british-bifurcation-coronary-study-compares-stenting-strategies March 1, 2010—David Hildick-Smith, MD, et al have published findings from BBC ONE (British Bifurcation Coronary Study) online ahead of print in Circulation. The BBC study was conducted because the optimal strategy for treating coronary bifurcation lesions remains a subject of debate. With bare-metal stents, single-st... Tue, 2 Feb 2010 04:00:00 GMT http://bmctoday.net/citoday/2010/02/article.asp?f=british-bifurcation-coronary-study-compares-stenting-strategies http://bmctoday.net/citoday/2010/02/article.asp?f=study-of-intracoronary-eptifibatide-for-pci-published February 16, 2010—In Circulation, Albert J. Deibele, MD, et al have published findings from an evaluation of intracoronary eptifibatide bolus administration during percutaneous coronary revascularization for acute coronary syndromes with evaluation of platelet glycoprotein IIb/IIIa receptor occupancy and platelet function (2010;121:784 --... Tue, 2 Feb 2010 04:00:00 GMT http://bmctoday.net/citoday/2010/02/article.asp?f=study-of-intracoronary-eptifibatide-for-pci-published http://bmctoday.net/citoday/2010/02/article.asp?f=crush-and-kissing-techniques-in-des-implantation-compared February 15, 2010—Curtiss T. Stinis, MD, et al conducted a study to compare the very long-term clinical outcomes of drug-eluting stent implantation of coronary artery bifurcation lesions using the crush and the simultaneous kissing stent (SKS) techniques. The 3-year outcomes were published in Catheterization and Cardiovascular Interventio... Tue, 2 Feb 2010 04:00:00 GMT http://bmctoday.net/citoday/2010/02/article.asp?f=crush-and-kissing-techniques-in-des-implantation-compared http://bmctoday.net/citoday/2010/02/article.asp?f=fda-grants-hde-approval-for-medtronics-melody-valve January 25, 2010—Medtronic, Inc. (Minneapolis, MN) announced that its Melody transcatheter pulmonary valve has received US Food and Drug Administration (FDA) approval under a humanitarian device exemption (HDE). The company noted that HDE approval is for treatments intended for fewer than 4,000 patients per year in the United States. HD... Tue, 2 Feb 2010 04:00:00 GMT http://bmctoday.net/citoday/2010/02/article.asp?f=fda-grants-hde-approval-for-medtronics-melody-valve http://bmctoday.net/citoday/2010/02/article.asp?f=fda-drafts-guidance-for-heart-valve-applications January 20, 2010—The US Food and Drug Administration’s (FDA) Center for Devices and Radiological Health has posted a draft guidance document for industry and FDA staff regarding investigational device exemption (IDE) and premarket approval (PMA) applications for heart valves. Comments and suggestions regarding this draft document shou... Tue, 2 Feb 2010 04:00:00 GMT http://bmctoday.net/citoday/2010/02/article.asp?f=fda-drafts-guidance-for-heart-valve-applications http://bmctoday.net/citoday/2010/02/article.asp?f=fda-approves-study-of-csis-diamondback-360deg-in-cad January 14, 2010—Cardiovascular Systems, Inc. (CSI, St. Paul, MN) has received conditional investigational device exemption (IDE) approval from the US Food and Drug Administration (FDA) to evaluate the safety and effectiveness of the company’s Diamondback 360° orbital atherectomy catheter system for treating calcified coronary lesion... Tue, 2 Feb 2010 04:00:00 GMT http://bmctoday.net/citoday/2010/02/article.asp?f=fda-approves-study-of-csis-diamondback-360deg-in-cad